Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

SYNCHRON LX20 CLINICAL SYSTEMS, CREATININE TEST SYSTEMS

K-Number: K071277 · 2007-06-01

ApplicantBeckman Coulter, Inc.
Decision Date2007-06-01
Product CodeCGX
Advisory CommitteeCH
DecisionSubstantially Equivalent

Device Summary

SYNCHRON LX20 CLINICAL SYSTEMS, CREATININE TEST SYSTEMS is the device name listed in this FDA 510(k) record. The listed applicant is Beckman Coulter, Inc.. It received FDA 510(k) clearance on 2007-06-01 under 510(k) number K071277. The device is classified under product code CGX. It was reviewed by the CH advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the SYNCHRON LX20 CLINICAL SYSTEMS, CREATININE TEST SYSTEMS?

SYNCHRON LX20 CLINICAL SYSTEMS, CREATININE TEST SYSTEMS is a medical device that received FDA 510(k) clearance on 2007-06-01. The listed applicant is Beckman Coulter, Inc.. The 510(k) number is K071277.

When did SYNCHRON LX20 CLINICAL SYSTEMS, CREATININE TEST SYSTEMS receive FDA 510(k) clearance?

SYNCHRON LX20 CLINICAL SYSTEMS, CREATININE TEST SYSTEMS received FDA 510(k) clearance on 2007-06-01, under 510(k) number K071277.

Who is the listed applicant for SYNCHRON LX20 CLINICAL SYSTEMS, CREATININE TEST SYSTEMS?

The FDA 510(k) record lists Beckman Coulter, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for SYNCHRON LX20 CLINICAL SYSTEMS, CREATININE TEST SYSTEMS?

The FDA product code for SYNCHRON LX20 CLINICAL SYSTEMS, CREATININE TEST SYSTEMS is CGX.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Beckman Coulter, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K262109Access NT-proBNPK252169Access BNP IIK254059Access anti-HBc IgMK253687Access anti-HBc TotalK251995Access anti-HAV IgMK250588Access Rubella IgG

View all 261 devices →

Related Devices (Code: CGX)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K252206Nova Allegro UACR Assay, Nova Allegro AnalyzerNova Biomedical CorporationK251058Tru Kidney Health Test Panel; Tru AnalyzerTruvian HealthK242685Atellica® CH Creatinine_3 (Crea3)Siemens Healthcare Diagnostics, Inc.K221813Nova Allegro UACR Assay, Nova Allegro AnalyzerNova Biomedical CorporationK210452Creatinine2Abbott Ireland Diagnostics DivisionK161494Atellica CH Creatinine_2 (Crea_2), Atellica CH Chemistry Calibrator (CHEM CAL)Siemens Healthcare Diagnostics, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑